Sarepta Therapeutics (SRPT) PT Raised to $35 at Baird
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $17.27 +0.06%
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 32
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- Dai-ichi Life Holdings, Inc (8750:JP) (DCNSF) PT Raised to JPY1,900 at JPMorgan
- EQT Corp. (EQT) PT Lowered to $65 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
